Literature DB >> 11159573

Delirium: optimising management.

D J Meagher1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11159573      PMCID： PMC1119415          DOI： 10.1136/bmj.322.7279.144

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  37 in total

Review 1.  How many, how old, how soon?

Authors:  K T Khaw
Journal:  BMJ       Date:  1999-11-20

2.  Trazodone in the treatment of delirium.

Authors:  Y Okamoto; Y Matsuoka; T Sasaki; H Jitsuiki; J Horiguchi; S Yamawaki
Journal:  J Clin Psychopharmacol       Date:  1999-06       Impact factor: 3.153

3.  Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium.

Authors:  L Tune; S Carr; E Hoag; T Cooper
Journal:  Am J Psychiatry       Date:  1992-10       Impact factor: 18.112

4.  Progression and Resolution of Delirium in Elderly Patients Hospitalized for Acute Care.

Authors:  Sue E Levkoff; Benjamin Liptzin; Denis A Evans; Paul D Cleary; Lewis A Lipsitz; Terrie Wetle; John W Rowe
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-28       Impact factor: 4.105

5.  A multicomponent intervention to prevent delirium in hospitalized older patients.

Authors:  S K Inouye; S T Bogardus; P A Charpentier; L Leo-Summers; D Acampora; T R Holford; L M Cooney
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

Review 6.  Treatment of delirium in the critically ill patient.

Authors:  D N Fish
Journal:  Clin Pharm       Date:  1991-06

7.  A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers.

Authors:  J N Beuzen; N Taylor; K Wesnes; A Wood
Journal:  J Psychopharmacol       Date:  1999       Impact factor: 4.153

Review 8.  Clinical subtypes of delirium in the elderly.

Authors:  S T O'Keeffe
Journal:  Dement Geriatr Cogn Disord       Date:  1999 Sep-Oct       Impact factor: 2.959

Review 9.  Sensory-perceptual alterations: delirium in the intensive care unit.

Authors:  C Easton; F MacKenzie
Journal:  Heart Lung       Date:  1988-05       Impact factor: 2.210

10.  Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines.

Authors:  M A Menza; G B Murray; V F Holmes; W A Rafuls
Journal:  Heart Lung       Date:  1988-05       Impact factor: 2.210
View more
  46 in total

1.  Optimising management of delirium. Placebo controlled trials of pharmacological treatments are needed.

Authors:  C J Ryan
Journal:  BMJ       Date:  2001-06-30

2.  Violence in the workplace. Delirium should be considered.

Authors:  Siobhan MacHale
Journal:  BMJ       Date:  2002-03-30

Review 3.  Clinical pharmacology of old age syndromes.

Authors:  C Broadhurst; K C M Wilson; M T Kinirons; A Wagg; J K Dhesi
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

Review 4.  An approach to drug induced delirium in the elderly.

Authors:  K Alagiakrishnan; C A Wiens
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

Review 5.  Research issues in the evaluation of cognitive impairment in intensive care unit survivors.

Authors:  James C Jackson; Sharon M Gordon; E Wesley Ely; Candice Burger; Ramona O Hopkins
Journal:  Intensive Care Med       Date:  2004-09-15       Impact factor: 17.440

Review 6.  Delirium in advanced disease.

Authors:  Dylan Harris
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

7.  [Postoperative delirium].

Authors:  S Pourhassan
Journal:  Chirurg       Date:  2006-09       Impact factor: 0.955

8.  Reevaluating recovery: perceived violations and preemptive interventions on emergency psychiatry rounds.

Authors:  Trevor Cohen; Brett Blatter; Carlos Almeida; Vimla L Patel
Journal:  J Am Med Inform Assoc       Date:  2007-02-28       Impact factor: 4.497

Review 9.  The syndrome of excited delirium.

Authors:  James R Gill
Journal:  Forensic Sci Med Pathol       Date:  2014-02-14       Impact factor: 2.007

Review 10.  Central nervous system toxicity from cancer treatment.

Authors:  Terri Armstrong; Mark R Gilbert
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.